SBC Fail-to-Deliver

SBC Medical Group Holdings Incorporated (SBC) operates in the Industrials sector, specifically the Consulting Services industry, with a market capitalization near $318.8M, listed on NASDAQ, employing roughly 863 people, carrying a beta of 0.61 to the broader market. SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. Led by Yoshiyuki Aikawa, public since 2022-09-26.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-05-14
Latest FTD Quantity
57.7K
Latest Price
$3.23
30-Day Avg FTD
15.2K
30-Day Total FTD
454.5K

Showing 30 days of SEC fail-to-deliver data for SBC Medical Group Holdings Incorporated.

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked SBC fail to deliver questions

What is the latest SBC fail-to-deliver count?
As of May 14, 2026, SBC Medical Group Holdings Incorporated (SBC) fail-to-deliver quantity is 57.7K shares, with a 30-day average of 15.2K shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do SBC FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.